Pembro Before and After Melanoma Surgery Boosts Outcomes

Patients with advanced melanoma have better event-free survival if pembrolizumab is given both before and after surgery; the findings tally with the mechanism of action of the drug, say researchers.
Medscape Medical News

source https://www.medscape.com/viewarticle/988932?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees

The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors